Shares of Prevail Therapeutics Inc. (PRVL) have gained more than 75% over the last three months, thanks to the progress on its pipeline of AAV-based gene therapies for patients with neurodegenerative disorders.
from RTT - Biotech https://ift.tt/37PkdzJ
via IFTTT
No comments:
Post a Comment